← 產業報告目錄
Oral Rinses Market by Product Type (Therapeutic, Cosmetic, Other Rinses), Indication (General Oral Health, Gingivitis & Periodontal Diseases), Distribution Channel (Consumer Stores, Retail Pharmacies, Dental Dispensaries), Region - Global Forecast to 2030
授權報價
| Single User Licence | $4,950 USD |
| Multi User Licence | $6,650 USD |
| Corporate User Licence | $8,150 USD |
| Global User Licence | $10,000 USD |
報告摘要
Growing awareness of advanced oral care products, along with a rising global population, is expected to drive the growth of the oral rinses market. Continuous innovation in formulation technologies, including the use of fluoride variants, essential oils, herbal actives, and alcohol-free bases, is improving product effectiveness, safety, and appeal to consumers. These improvements are increasing the effectiveness, availability, and attractiveness of oral rinses to a broader range of customers and clinical uses. Demand is also growing due to an increase in dental diseases and an aging population in need of additional oral care. However, broader market adoption may be limited by the high cost of therapeutic mouthwash and, in some markets, low consumer acceptance or adherence.
By product type, the therapeutic rinses segment had the largest share of the global oral rinses market.
The global oral rinses market is divided into three main segments: therapeutic rinses, cosmetic rinses, and others. The therapeutic rinses segment dominates the oral hygiene market due to their significant functional advantages and clinical endorsement. These formulations are enriched with active agents that effectively lower bacterial loads, mitigate the risk of periodontal diseases, and promote enamel integrity. They are specifically engineered to address the etiology of oral health issues rather than merely alleviating symptoms. Key drivers for their adoption include professional recommendations from dentists, an increasing consumer emphasis on long-term oral health maintenance, and heightened awareness of the correlation between oral health and systemic conditions. The accessibility of these products in both clinical environments and retail outlets further amplifies their market penetration.
The general oral health segment commanded the largest share of the global oral rinses market based on indication.
The global oral rinses market is divided into several categories based on indication: general oral health, gingivitis & periodontal diseases, halitosis, dry mouth, and other conditions. The general oral health segment is anticipated to command the largest share of the market due to its expansive positioning, enabling manufacturers to engage a diverse consumer base, including individuals focused on preventive oral care. Contributing factors to this segment's growth include enhanced accessibility, minimal regulatory constraints, and robust retail visibility. Furthermore, strategic brand-centric marketing initiatives have been pivotal in embedding general-use mouthwashes into daily personal care regimens globally, thereby reinforcing their market dominance. This segment exhibits relatively stable demand trajectories, making it an appealing prospect for long-term investment strategies. Leading industry players have consistently prioritized this category within their portfolios, recognizing it as a principal contributor to sales volume and market share expansion.
By distribution channel, the consumer stores segment accounted for the largest share of the global oral rinses market.
The global oral rinses market is divided by distribution channel into consumer stores, retail pharmacies & dental dispensaries, and online sales. Consumer retail outlets dominate the oral rinses market, attributed to their extensive physical presence, high in-store brand visibility, and the convenience they afford to everyday shoppers. Supermarkets and general retail establishments facilitate direct access to a diverse range of products, enabling consumers to easily compare brands. Additionally, these venues frequently implement promotional strategies and incentives that stimulate impulse purchasing behaviors. The integration of oral care products into routine grocery shopping significantly boosts sales volumes through this channel. Furthermore, established collaborations with fast-moving consumer goods (FMCG) distributors and optimized shelf placement strategies enhance their competitive advantage within the market.
The Asia Pacific is expected to grow at the highest CAGR in the oral rinses market during the forecast period.
The rapid growth of the population in the Asia Pacific region, coupled with a rising demand for sophisticated oral care solutions, is significantly driving the market for oral rinses. As the middle class expands, consumer interest in maintaining oral health has surged, leading to a greater emphasis on the importance of effective oral hygiene products. In response to these trends, leading global companies in the oral care industry are strategically increasing their presence in this dynamic market. They are doing so by introducing innovative formulations that cater to diverse needs, such as whitening, sensitivity relief, and antibacterial properties, as well as launching digitally integrated oral hygiene solutions that promote seamless user experiences. Moreover, indication-specific mouthwashes designed to target particular oral health issues are becoming increasingly popular, further contributing to the robust demand for oral rinses across the region.
A breakdown of the primary participants (supply side) for the oral rinses market referred to in this report is provided below:
• By Company Type: Tier 1 (30%), Tier 2 (35%), and Tier 3 (35%)
• By Designation: C-level Executives (20%), Directors (35%), and Others (45%)
• By Region: North America (30%), Europe (25%), Asia Pacific (20%), Latin America (20%), Middle East & Africa (2%), GCC Countries (3%)
Prominent players in the oral rinses market include Colgate-Palmolive Company (US), Kenvue (US), Procter & Gamble (US), Haleon Group of Companies (UK), Unilever (UK), Church & Dwight Co., Inc. (US), Lion Corporation (Japan), Amway (US), SUNSTAR Suisse S.A. (Switzerland), Perrigo Company plc (Ireland), Dabur (India), Himalaya Wellness Company (India), Kao Corporation (Japan), Opella Healthcare Group SAS (France), SmartMouth Oral Health Laboratories (US), Dentaid Ltd. (Spain), CloSYS (US), SCANDERRA GmbH (Switzerland), Pearlie White (Singapore), Dr. Wild & Co. AG (Switzerland), Boka (US), Perfora (India), Salt Oral Care (India), OraBio, Inc. (US), and Lumineux (US).
Research Coverage
The report offers an analysis of the oral rinses market, focusing on estimating the market size and potential for future growth across various segments, including distribution channels, regions, indications, and product types. Additionally, the report includes a competitive analysis of major market players, detailing their company profiles, product and service offerings, recent developments, and key strategies.
Reasons to Buy the Report
The report delivers critical insights for industry leaders and new entrants within the oral rinses sector, presenting estimated revenue projections for the overall market as well as its distinct segments. It facilitates a comprehensive understanding of the competitive landscape, enabling stakeholders to effectively position their businesses and devise robust go-to-market strategies. Furthermore, the document delineates key market drivers, constraints, challenges, and opportunities, equipping stakeholders to evaluate prevailing market conditions with a high degree of accuracy.
This report provides insights into the following pointers:
Analysis of key drivers (high incidence of dental diseases, product innovation and advanced formulations), restraints (side effects from prolonged use, competition from alternative products), opportunities (rising trend of online purchasing and e-commerce, growing awareness about oral hygiene), and challenges (limited penetration in rural areas, high price points limit broader consumer adoption).
• Market Penetration: This report provides detailed information on the product portfolios offered by major players in the global oral rinses market. It covers various segments, including product types, indications, distribution channels, and regions.
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global oral rinses market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets by product type, indication, distribution channel, and region.
• Market Diversification: Comprehensive information about newly launched products and services, expanding markets, current advancements, and investments in the global oral rinses market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of products and services, and capacities of the major competitors in the global oral rinses market.
目錄 Table of Contents
1 INTRODUCTION 24
1.1 STUDY OBJECTIVES 24
1.2 MARKET DEFINITION 24
1.3 STUDY SCOPE 25
1.3.1 ORAL RINSES MARKET SEGMENTATION & REGIONAL SCOPE 25
1.3.2 INCLUSIONS & EXCLUSIONS 26
1.3.3 YEARS CONSIDERED 27
1.3.4 CURRENCY CONSIDERED 27
1.4 STAKEHOLDERS 28
2 RESEARCH METHODOLOGY 29
2.1 RESEARCH DATA 29
2.1.1 SECONDARY DATA 30
2.1.1.1 Key secondary sources 30
2.1.1.2 Key data from secondary sources 31
2.1.2 PRIMARY DATA 31
2.1.2.1 Objectives of primary research 32
2.1.2.2 Key data from primary sources 32
2.1.2.3 Key industry insights 33
2.2 MARKET SIZE ESTIMATION 34
2.2.1 REVENUE SHARE ANALYSIS 34
2.2.2 BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS) 37
2.2.3 COMPANY PRESENTATIONS & PRIMARY INTERVIEWS 37
2.2.4 TOP-DOWN APPROACH 39
2.3 DATA TRIANGULATION 39
2.4 MARKET SHARE ESTIMATION 40
2.5 STUDY ASSUMPTIONS 40
2.6 RESEARCH LIMITATIONS 41
2.6.1 SCOPE-RELATED LIMITATIONS 41
2.6.2 METHODOLOGY-RELATED LIMITATIONS 41
2.7 RISK ANALYSIS 41
3 EXECUTIVE SUMMARY 42
4 PREMIUM INSIGHTS 45
4.1 ORAL RINSES MARKET OVERVIEW 45
4.2 ASIA PACIFIC: ORAL RINSES MARKET, BY PRODUCT TYPE AND COUNTRY 46
4.3 ORAL RINSES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 47
4.4 ORAL RINSES MARKET: REGIONAL MIX 47
4.5 ORAL RINSES MARKET: DEVELOPED VS. EMERGING MARKETS, 2025 VS. 2030 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
5.2.1 DRIVERS 50
5.2.1.1 High incidence of chronic dental diseases 50
5.2.1.2 Increasing household purchasing power of middle-class population in emerging economies 50
5.2.1.3 Rising focus on creating public awareness and targeted educational campaigns 50
5.2.2 RESTRAINTS 51
5.2.2.1 High cost of therapeutic and specialty formula-based oral rinses 51
5.2.2.2 Side effects from prolonged use of therapeutic and alcohol-based mouthwashes 51
5.2.3 OPPORTUNITIES 51
5.2.3.1 Rising trends of online purchasing and e-commerce 51
5.2.4 CHALLENGES 52
5.2.4.1 Rising number of product recalls 52
5.2.4.2 Limited penetration in rural and semi-urban areas in emerging economies 52
5.3 INDUSTRY TRENDS 53
5.3.1 STRATEGIC DEMERGER OF CONSUMER HEALTHCARE DIVISIONS BY LEADING PHARMACEUTICAL COMPANIES 53
5.3.2 RISE OF NATURAL AND HERBAL ORAL RINSES AMID CLEAN-LABEL CONSUMER SHIFT 53
5.4 TECHNOLOGY ANALYSIS 54
5.4.1 KEY TECHNOLOGIES 54
5.4.1.1 Flouride 54
5.4.1.2 Anti-microbial agents 54
5.4.2 COMPLEMENTARY TECHNOLOGIES 54
5.4.2.1 Essential oils 54
5.4.3 ADJACENT TECHNOLOGIES 55
5.4.3.1 Electric dental flossers 55
5.5 PRICING ANALYSIS 55
5.5.1 AVERAGE SELLING PRICE TREND OF ORAL RINSES, BY KEY PLAYER,
2022–2024 55
5.5.2 AVERAGE SELLING PRICE TREND OF ORAL RINSES, BY REGION, 2022–2024 55
5.6 ECOSYSTEM ANALYSIS 56
5.6.1 ROLE IN ECOSYSTEM 57
5.7 REIMBURSEMENT SCENARIO ANALYSIS 58
5.8 VALUE CHAIN ANALYSIS 58
5.9 PORTER’S FIVE FORCES ANALYSIS 59
5.9.1 INTENSITY OF COMPETITIVE RIVALRY 61
5.9.2 BARGAINING POWER OF SUPPLIERS 61
5.9.3 BARGAINING POWER OF BUYERS 61
5.9.4 THREAT OF SUBSTITUTES 61
5.9.5 THREAT OF NEW ENTRANTS 61
5.10 KEY STAKEHOLDERS & BUYING CRITERIA 62
5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS 62
5.10.2 KEY BUYING CRITERIA 62
5.11 SUPPLY CHAIN ANALYSIS 63
5.12 TRADE ANALYSIS 64
5.12.1 IMPORT DATA FOR HS CODE 330690, 2020–2024 64
5.12.2 EXPORT DATA FOR HS CODE 330690, 2020–2024 65
5.13 REGULATORY ANALYSIS 65
5.13.1 REGULATORY FRAMEWORK 65
5.13.1.1 North America 65
5.13.1.1.1 US 65
5.13.1.2 European Union 66
5.13.1.3 Asia Pacific 66
5.13.1.3.1 China 66
5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 67
5.14 PATENT ANALYSIS 69
5.14.1 PATENT PUBLICATION TRENDS FOR ORAL RINSES MARKET 69
5.14.2 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN
ORAL RINSES MARKET 69
5.14.3 LIST OF MAJOR PATENTS 71
5.15 KEY CONFERENCES & EVENTS, 2025–2026 72
5.16 ADJACENT MARKET ANALYSIS 73
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73
5.18 UNMET NEEDS/END-USER EXPECTATIONS 74
5.18.1 UNMET NEEDS 74
5.18.2 END-USER EXPECTATIONS 75
5.19 IMPACT OF AI/GEN AI ON ORAL RINSES MARKET 75
5.20 CASE STUDY ANALYSIS 76
5.20.1 CAPHOSOL ORAL RINSE TO EFFECTIVELY MANAGE
CHEMOTHERAPY-INDUCED ORAL MUCOSITIS 76
5.20.2 ANTISPECTIC MOUTHWASHES TO PREVENT VENTILATOR-ASSOCIATED PNEUMONIA (VAP) AMONG MECHANICALLY VENTILATED PATIENTS 77
5.20.3 HERBAL MOUTHRINSE TO BE EFFECIVE FOR CHLORHEXIDINE WITHOUT ADVERSE EFFECTS 77
5.21 INVESTMENT & FUNDING SCENARIO 78
5.22 IMPACT OF 2025 US TARIFF ON ORAL RINSES MARKET 78
5.22.1 INTRODUCTION 78
5.22.2 KEY TARIFF RATES 79
5.22.3 KEY TARIFF RATES 79
5.22.4 PRICE IMPACT ANALYSIS 80
5.22.5 IMPACT ON COUNTRY/REGION 80
5.22.5.1 North America 80
5.22.5.1.1 US 80
5.22.5.2 Europe 80
5.22.5.3 Asia Pacific 81
5.22.6 IMPACT ON END-USE INDUSTRIES 81
6 ORAL RINSES MARKET, BY PRODUCT TYPE 82
6.1 INTRODUCTION 83
6.2 THERAPEUTIC RINSES 83
6.2.1 INCREASING PREVALENCE OF ORAL DISEASES TO
BOOST ADOPTION OF THERAPEUTIC RINSES 83
6.3 COSMETIC RINSES 84
6.3.1 RISE IN AESTHETIC CONSCIOUSNESS TO PROMOTE
ADOPTION OF COSMETIC RINSES 84
6.4 OTHER RINSES 86
7 ORAL RINSES MARKET, BY INDICATION 88
7.1 INTRODUCTION 89
7.2 GENERAL ORAL HEALTH 89
7.2.1 GENERAL USE MOUTHWASHES TO REDUCE PLAQUE, FRESHEN BREATH, SUPPORT GUM HEALTH, AND ENHANCE ORAL CLEANLINESS 89
7.3 GINGIVITIS & PERIODONTAL DISEASES 90
7.3.1 WIDESPREAD PREVALENCE OF GUM-RELATED CONDITIONS AND HIGH DEMAND FOR NON-INVASIVE TREATMENTS TO DRIVE MARKET 90
7.4 HALITOSIS 92
7.4.1 RISING AESTHETIC CONSCIOUSNESS TO FUEL ADOPTION OF ORAL RINSES FOR BAD BREATH 92
7.5 DRY MOUTH 93
7.5.1 RISING GERIATRIC POPULATION WITH CHRONIC DISEASES TO PROPEL SEGMENT GROWTH 93
7.6 OTHER INDICATIONS 94
8 ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL 96
8.1 INTRODUCTION 97
8.2 CONSUMER STORES 97
8.2.1 BROAD ACCESSIBILITY, IN-STORE MARKETING, AND SEASONAL PROMOTIONS TO INCREASE SALES IN CONSUMER STORE 97
8.3 RETAIL PHARMACIES & DENTAL DISPENSARIES 99
8.3.1 STRONG CLINICAL ENDORSEMENT AND INCREASED CONSUMER TRUST TO FUEL SALES OF ORAL RINSES 99
8.4 ONLINE DISTRIBUTION 100
8.4.1 RISE IN INTERNET USE, EVOLVED DIGITAL SHOPPING HABITS, AND CONVENIENCE OF DIRECT-TO-DOOR DELIVERY TO DRIVE MARKET 100
9 ORAL RINSES MARKET, BY REGION 102
9.1 INTRODUCTION 103
9.2 NORTH AMERICA 104
9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 104
9.2.2 US 107
9.2.2.1 US to dominate North American oral rinses market during forecast period 107
9.2.3 CANADA 109
9.2.3.1 Better network of dental professionals and robust healthcare infrastructure to propel market growth 109
9.3 EUROPE 111
9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 111
9.3.2 GERMANY 113
9.3.2.1 High prevalence of edentulism and willingness to invest in advanced personal care products to augment market growth 113
9.3.3 UK 115
9.3.3.1 Rising geriatric population and increasing demand for oral hygiene products to encourage market growth 115
9.3.4 FRANCE 117
9.3.4.1 Persistent burden of dental diseases and favorable government initiatives to spur market growth 117
9.3.5 ITALY 118
9.3.5.1 Aging demographic and prevalence of chronic dental diseases to aid market growth 118
9.3.6 SPAIN 120
9.3.6.1 Strong dental care infrastructure and high focus on quality healthcare to support market growth 120
9.3.7 SWITZERLAND 122
9.3.7.1 Focus on high standard of living to drive popularity of advanced oral hygiene products 122
9.3.8 POLAND 123
9.3.8.1 Strong public healthcare system and wider access to high-quality dental care products to propel market growth 123
9.3.9 REST OF EUROPE 125
9.4 ASIA PACIFIC 126
9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 127
9.4.2 CHINA 130
9.4.2.1 Focus on oral hygiene and high burden of age-related dental conditions to fuel demand for preventive oral care products 130
9.4.3 JAPAN 132
9.4.3.1 Strong dental health awareness and presence of key players to augment market growth 132
9.4.4 INDIA 133
9.4.4.1 Increasing awareness about dental health and growing consumer purchasing power to support market growth 133
9.4.5 AUSTRALIA 135
9.4.5.1 Favorable government initiatives and high incidence of dental diseases to accelerate market growth 135
9.4.6 SOUTH KOREA 137
9.4.6.1 Rising disposable income and increasing demand for advanced dental care solutions to favor market growth 137
9.4.7 REST OF ASIA PACIFIC 139
9.5 LATIN AMERICA 140
9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 140
9.5.2 BRAZIL 142
9.5.2.1 High rate of urbanization to sustain demand for quality oral care products 142
9.5.3 MEXICO 144
9.5.3.1 Easy access to modern dental clinics, pharmacies, and e-commerce platforms to aid market growth 144
9.5.4 REST OF LATIN AMERICA 146
9.6 MIDDLE EAST & AFRICA 147
9.6.1 EASY AVAILABILITY OF ORAL CARE PRODUCTS THROUGH URBAN CONVENIENCE STORES AND E-COMMERCE TO DRIVE MARKET 147
9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 148
9.7 GCC COUNTRIES 149
9.7.1 INCREASING DEMAND FOR ADAVNCED DENTAL CARE SERVICES TO AUGMENT MARKET GROWTH 149
9.7.2 MACROECONOMIC OUTLOOK FOR GCC COUNTRIES 150
10 COMPETITIVE LANDSCAPE 152
10.1 INTRODUCTION 152
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 152
10.2.1 OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN ORAL RINSES MARKET 153
10.3 REVENUE ANALYSIS, 2020–2024 154
10.4 MARKET SHARE ANALYSIS, 2024 154
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 156
10.5.1 STARS 156
10.5.2 EMERGING LEADERS 157
10.5.3 PERVASIVE PLAYERS 157
10.5.4 PARTICIPANTS 157
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 159
10.5.5.1 Company footprint 159
10.5.5.2 Region footprint 160
10.5.5.3 Product type footprint 161
10.5.5.4 Indication footprint 162
10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 163
10.6.1 PROGRESSIVE COMPANIES 163
10.6.2 RESPONSIVE COMPANIES 163
10.6.3 DYNAMIC COMPANIES 163
10.6.4 STARTING BLOCKS 163
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 165
10.6.5.1 Detailed list of key startups/SMEs 165
10.6.5.2 Competitive benchmarking of key startups/SMEs 165
10.7 COMPANY VALUATION & FINANCIAL METRICS 166
10.7.1 FINANCIAL METRICS 166
10.7.2 COMPANY VALUATION 166
10.8 BRAND/PRODUCT COMPARISON 167
10.9 R&D EXPENDITURE OF KEY PLAYERS 168
10.10 COMPETITIVE SCENARIO 168
10.10.1 PRODUCT LAUNCHES 168
10.10.2 DEALS 169
10.10.3 EXPANSIONS 170
10.10.4 OTHER DEVELOPMENTS 170
11 COMPANY PROFILES 171
11.1 KEY PLAYERS 171
11.1.1 KENVUE 171
11.1.1.1 Business overview 171
11.1.1.2 Products offered 172
11.1.1.3 Recent developments 174
11.1.1.3.1 Product launches 174
11.1.1.3.2 Deals 174
11.1.1.3.3 Expansions 174
11.1.1.4 MnM view 175
11.1.1.4.1 Right to win 175
11.1.1.4.2 Strategic choices 175
11.1.1.4.3 Weaknesses & competitive threats 175
11.1.2 COLGATE-PALMOLIVE COMPANY 176
11.1.2.1 Business overview 176
11.1.2.2 Products offered 177
11.1.2.3 Recent developments 178
11.1.2.3.1 Product launches 178
11.1.2.3.2 Deals 178
11.1.2.3.3 Other developments 179
11.1.2.4 MnM view 179
11.1.2.4.1 Right to win 179
11.1.2.4.2 Strategic choices 180
11.1.2.4.3 Weaknesses & competitive threats 180
11.1.3 PROCTER & GAMBLE 181
11.1.3.1 Business overview 181
11.1.3.2 Products offered 182
11.1.3.3 Recent developments 184
11.1.3.3.1 Product launches 184
11.1.3.3.2 Deals 184
11.1.3.4 MnM view 185
11.1.3.4.1 Right to win 185
11.1.3.4.2 Strategic choices 185
11.1.3.4.3 Weaknesses & competitive threats 185
11.1.4 HALEON GROUP OF COMPANIES 186
11.1.4.1 Business overview 186
11.1.4.2 Products offered 187
11.1.4.3 Recent developments 188
11.1.4.3.1 Product launches 188
11.1.4.3.2 Deals 188
11.1.4.3.3 Expansions 189
11.1.4.4 MnM view 189
11.1.4.4.1 Right to win 189
11.1.4.4.2 Strategic choices 190
11.1.4.4.3 Weaknesses & competitive threats 190
11.1.5 UNILEVER 191
11.1.5.1 Business overview 191
11.1.5.2 Products offered 192
11.1.5.3 Recent developments 193
11.1.5.3.1 Deals 193
11.1.5.4 MnM view 193
11.1.5.4.1 Right to win 193
11.1.5.4.2 Strategic choices 193
11.1.5.4.3 Weaknesses & competitive threats 194
11.1.6 CHURCH & DWIGHT CO., INC. 195
11.1.6.1 Business overview 195
11.1.6.2 Products offered 196
11.1.6.3 Recent developments 197
11.1.6.3.1 Product launches 197
11.1.6.3.2 Deals 197
11.1.7 LION CORPORATION 198
11.1.7.1 Business overview 198
11.1.7.2 Products offered 199
11.1.7.3 Recent developments 200
11.1.7.3.1 Product launches 200
11.1.7.3.2 Deals 200
11.1.7.3.3 Expansions 201
11.1.8 AMWAY CORP. 202
11.1.8.1 Business overview 202
11.1.8.2 Products offered 203
11.1.9 SUNSTAR SUISSE S.A. 204
11.1.9.1 Business overview 204
11.1.9.2 Products offered 205
11.1.9.3 Recent developments 206
11.1.9.3.1 Product launches 206
11.1.10 PERRIGO COMPANY PLC 207
11.1.10.1 Business overview 207
11.1.10.2 Products offered 208
11.1.10.3 Recent developments 209
11.1.10.3.1 Deals 209
11.1.11 DABUR 210
11.1.11.1 Business overview 210
11.1.11.2 Products offered 211
11.1.11.3 Recent developments 212
11.1.11.3.1 Deals 212
11.1.12 HIMALAYA WELLNESS COMPANY 213
11.1.12.1 Business overview 213
11.1.12.2 Products offered 213
11.1.13 KAO CORPORATION 214
11.1.13.1 Business overview 214
11.1.13.2 Products offered 215
11.1.14 OPELLA HEALTHCARE GROUP SAS 216
11.1.14.1 Business overview 216
11.1.14.2 Products offered 216
11.1.14.3 Recent developments 217
11.1.14.3.1 Deals 217
11.1.15 SMARTMOUTH ORAL HEALTH LABORATORIES 218
11.1.15.1 Business overview 218
11.1.15.2 Products offered 218
11.1.15.3 Recent developments 219
11.1.15.3.1 Product launches 219
11.2 OTHER PLAYERS 219
11.2.1 DENTAID 219
11.2.2 CLOSYS 220
11.2.3 SCANDERRA GMBH 221
11.2.4 PEARLIE WHITE 222
11.2.5 WILD 223
11.2.6 BOKA 224
11.2.7 PERFORA 225
11.2.8 SALT ORAL CARE 226
11.2.9 ORABIO 227
11.2.10 LUMINEUX 228
12 APPENDIX 229
12.1 DISCUSSION GUIDE 229
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 233
12.3 CUSTOMIZATION OPTIONS 235
12.4 RELATED REPORTS 235
12.5 AUTHOR DETAILS 237
圖表清單 List of Tables & Figures
TABLE 1 ORAL RINSES MARKET: INCLUSIONS & EXCLUSIONS 26
TABLE 2 STANDARD CURRENCY CONVERSION RATES 27
TABLE 3 ORAL RINSES MARKET: STUDY ASSUMPTIONS 40
TABLE 4 ORAL RINSES MARKET: RISK ANALYSIS 41
TABLE 5 AVERAGE SELLING PRICE TREND OF ORAL RINSES, BY KEY PLAYER,
2022–2024 (USD) 55
TABLE 6 AVERAGE SELLING PRICE TREND OF ORAL RINSES, BY REGION, 2022–2024 (USD) 56
TABLE 7 ORAL RINSES MARKET: ROLE IN ECOSYSTEM 57
TABLE 8 ORAL RINSES MARKET: PORTER’S FIVE FORCES 60
TABLE 9 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS,
BY DISTRIBUTION CHANNEL 62
TABLE 10 KEY BUYING CRITERIA FOR MAJOR DISTRIBUTION CHANNELS 63
TABLE 11 IMPORT DATA FOR HS CODE 330690, BY COUNTRY,
2020–2024 (USD THOUSAND) 64
TABLE 12 EXPORT DATA FOR HS CODE 330690, BY COUNTRY,
2020–2024 (USD THOUSAND) 65
TABLE 13 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 67
TABLE 14 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 67
TABLE 15 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 68
TABLE 16 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 69
TABLE 17 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 18 ORAL RINSES MARKET: LIST OF MAJOR PATENTS, 2022–2024 71
TABLE 19 ORAL RINSES MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2025–DECEMBER 2026 72
TABLE 20 ORAL RINSES MARKET: UNMET NEEDS 74
TABLE 21 ORAL RINSES MARKET: END-USER EXPECTATIONS 75
TABLE 22 CASE STUDY 1: CAPHOSOL ORAL RINSE TO EFFECTIVELY MANAGE CHEMOTHERAPY-INDUCED ORAL MUCOSITIS 76
TABLE 23 CASE STUDY 2: ANTISPETIC MOUTHWASHES TO PREVENT VENTILATOR-ASSOCIATED PNEUMONIA (VAP) AMONG MECHANICALLY VENTILATED PATIENTS 77
TABLE 24 CASE STUDY 3: HERBAL MOUTHRINSE TO BE EFFECIVE FOR CHLORHEXIDINE WITHOUT ADVERSE EFFECTS 77
TABLE 25 US-ADJUSTED RECIPROCAL TARIFF RATES 79
TABLE 26 KEY PRODUCT-RELATED TARIFFS EFFECTIVE FOR ORAL CARE PRODUCTS 80
TABLE 27 ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 83
TABLE 28 ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (MILLION UNITS) 83
TABLE 29 THERAPEUTIC ORAL RINSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 84
TABLE 30 COSMETIC ORAL RINSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 85
TABLE 31 OTHER ORAL RINSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 87
TABLE 32 ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 89
TABLE 33 ORAL RINSES MARKET FOR GENERAL ORAL HEALTH, BY COUNTRY,
2023–2030 (USD MILLION) 90
TABLE 34 ORAL RINSES MARKET FOR GINGIVITIS & PERIODONTAL DISEASES, BY COUNTRY, 2023–2030 (USD MILLION) 91
TABLE 35 ORAL RINSES MARKET FOR HALITOSIS, BY COUNTRY, 2023–2030 (USD MILLION) 93
TABLE 36 ORAL RINSES MARKET FOR DRY MOUTH, BY COUNTRY,
2023–2030 (USD MILLION) 94
TABLE 37 ORAL RINSES MARKET FOR OTHER INDICATIONS, BY COUNTRY,
2023–2030 (USD MILLION) 95
TABLE 38 ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 97
TABLE 39 ORAL RINSES MARKET FOR CONSUMER STORES, BY COUNTRY,
2023–2030 (USD MILLION) 98
TABLE 40 ORAL RINSES MARKET FOR RETAIL PHARMACIES & DENTAL DISPENSARIES,
BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 41 ORAL RINSES MARKET FOR ONLINE DISTRIBUTION, BY COUNTRY,
2023–2030 (USD MILLION) 101
TABLE 42 ORAL RINSES MARKET, BY REGION, 2023–2030 (USD MILLION) 104
TABLE 43 NORTH AMERICA: ORAL RINSES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 106
TABLE 44 NORTH AMERICA: ORAL RINSES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 106
TABLE 45 NORTH AMERICA: ORAL RINSES MARKET, BY INDICATION,
2023–2030 (USD MILLION) 106
TABLE 46 NORTH AMERICA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 107
TABLE 47 US: KEY MACROINDICATORS 108
TABLE 48 US: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 108
TABLE 49 US: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 108
TABLE 50 US: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 109
TABLE 51 CANADA: KEY MACROINDICATORS 110
TABLE 52 CANADA: ORAL RINSES MARKET, BY PRODUCT TYPE , 2023–2030 (USD MILLION) 110
TABLE 53 CANADA: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 110
TABLE 54 CANADA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 111
TABLE 55 EUROPE: ORAL RINSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112
TABLE 56 EUROPE: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 112
TABLE 57 EUROPE: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 113
TABLE 58 EUROPE: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 113
TABLE 59 GERMANY: KEY MACROINDICATORS 114
TABLE 60 GERMANY: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 114
TABLE 61 GERMANY: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 114
TABLE 62 GERMANY: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 115
TABLE 63 UK: KEY MACROINDICATORS 115
TABLE 64 UK: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 116
TABLE 65 UK: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 116
TABLE 66 UK: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 116
TABLE 67 FRANCE: KEY MACROINDICATORS 117
TABLE 68 FRANCE: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 117
TABLE 69 FRANCE: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 118
TABLE 70 FRANCE: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 118
TABLE 71 ITALY: KEY MACROINDICATORS 119
TABLE 72 ITALY: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 119
TABLE 73 ITALY: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 119
TABLE 74 ITALY: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 120
TABLE 75 SPAIN: KEY MACROINDICATORS 120
TABLE 76 SPAIN: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 121
TABLE 77 SPAIN: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 121
TABLE 78 SPAIN: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 121
TABLE 79 SWITZERLAND: KEY MACROINDICATORS 122
TABLE 80 SWITZERLAND: ORAL RINSES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 122
TABLE 81 SWITZERLAND: ORAL RINSES MARKET, BY INDICATION,
2023–2030 (USD MILLION) 123
TABLE 82 SWITZERLAND: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 123
TABLE 83 POLAND: KEY MACROINDICATORS 124
TABLE 84 POLAND: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 124
TABLE 85 POLAND: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 124
TABLE 86 POLAND: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 125
TABLE 87 REST OF EUROPE: ORAL RINSES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 125
TABLE 88 REST OF EUROPE: ORAL RINSES MARKET, BY INDICATION,
2023–2030 (USD MILLION) 126
TABLE 89 REST OF EUROPE: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 126
TABLE 90 ASIA PACIFIC: ORAL RINSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129
TABLE 91 ASIA PACIFIC: ORAL RINSES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 129
TABLE 92 ASIA PACIFIC: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 129
TABLE 93 ASIA PACIFIC: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 130
TABLE 94 CHINA: KEY MACROINDICATORS 130
TABLE 95 CHINA: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 131
TABLE 96 CHINA: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 131
TABLE 97 CHINA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 131
TABLE 98 JAPAN: KEY MACROINDICATORS 132
TABLE 99 JAPAN: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 132
TABLE 100 JAPAN: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 133
TABLE 101 JAPAN: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 133
TABLE 102 INDIA: KEY MACROINDICATORS 134
TABLE 103 INDIA: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 134
TABLE 104 INDIA: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 135
TABLE 105 INDIA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 135
TABLE 106 AUSTRALIA: KEY MACROINDICATORS 136
TABLE 107 AUSTRALIA: ORAL RINSES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 136
TABLE 108 AUSTRALIA: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 136
TABLE 109 AUSTRALIA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 137
TABLE 110 SOUTH KOREA: KEY MACROINDICATORS 137
TABLE 111 SOUTH KOREA: ORAL RINSES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 138
TABLE 112 SOUTH KOREA: ORAL RINSES MARKET, BY INDICATION,
2023–2030 (USD MILLION) 138
TABLE 113 SOUTH KOREA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 138
TABLE 114 REST OF ASIA PACIFIC: ORAL RINSES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 139
TABLE 115 REST OF ASIA PACIFIC: ORAL RINSES MARKET, BY INDICATION,
2023–2030 (USD MILLION) 139
TABLE 116 REST OF ASIA PACIFIC: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 140
TABLE 117 LATIN AMERICA: ORAL RINSES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 118 LATIN AMERICA: ORAL RINSES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 141
TABLE 119 LATIN AMERICA: ORAL RINSES MARKET, BY INDICATION,
2023–2030 (USD MILLION) 142
TABLE 120 LATIN AMERICA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 142
TABLE 121 BRAZIL: KEY MACROINDICATORS 143
TABLE 122 BRAZIL: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 143
TABLE 123 BRAZIL: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 143
TABLE 124 BRAZIL: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 144
TABLE 125 MEXICO: KEY MACROINDICATORS 144
TABLE 126 MEXICO: ORAL RINSES MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 145
TABLE 127 MEXICO: ORAL RINSES MARKET, BY INDICATION, 2023–2030 (USD MILLION) 145
TABLE 128 MEXICO: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 145
TABLE 129 REST OF LATIN AMERICA: ORAL RINSES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 146
TABLE 130 REST OF LATIN AMERICA: ORAL RINSES MARKET, BY INDICATION,
2023–2030 (USD MILLION) 147
TABLE 131 REST OF LATIN AMERICA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 147
TABLE 132 MIDDLE EAST & AFRICA: ORAL RINSES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 148
TABLE 133 MIDDLE EAST & AFRICA: ORAL RINSES MARKET, BY INDICATION,
2023–2030 (USD MILLION) 149
TABLE 134 MIDDLE EAST & AFRICA: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL, 2023–2030 (USD MILLION) 149
TABLE 135 GCC COUNTRIES: ORAL RINSES MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 150
TABLE 136 GCC COUNTRIES: ORAL RINSES MARKET, BY INDICATION,
2023–2030 (USD MILLION) 151
TABLE 137 GCC COUNTRIES: ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2023–2030 (USD MILLION) 151
TABLE 138 MAJOR STRATEGIES DEPLOYED BY KEY PLAYERS IN ORAL RINSES MARKET, JANUARY 2022–JUNE 2025 153
TABLE 139 ORLA RINSES MARKET: DEGREE OF COMPETITION 155
TABLE 140 ORAL RINSES MARKET: REGION FOOTPRINT 160
TABLE 141 ORAL RINSES MARKET: PRODUCT TYPE FOOTPRINT 161
TABLE 142 ORAL RINSES MARKET: INDICATION FOOTPRINT 162
TABLE 143 ORAL RINSES MARKET: DETAILED LIST OF KEY STARTUPS/SME PLAYERS 165
TABLE 144 ORAL RINSES MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SME PLAYERS, BY PRODUCT TYPE AND REGION 165
TABLE 145 ORAL RINSES MARKET: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 168
TABLE 146 ORAL RINSES MARKET: DEALS, JANUARY 2022–JUNE 2025 169
TABLE 147 ORAL RINSES MARKET: EXPANSIONS, JANUARY 2022–JUNE 2025 170
TABLE 148 ORAL RINSES MARKET: OTHER DEVELOPMENTS,
JANUARY 2022–JUNE 2025 170
TABLE 149 KENVUE: COMPANY OVERVIEW 171
TABLE 150 KENVUE: PRODUCTS OFFERED 172
TABLE 151 KENVUE: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 174
TABLE 152 KENVUE: DEALS, JANUARY 2022–JUNE 2025 174
TABLE 153 KENVUE: EXPANSIONS, JANUARY 2022–JUNE 2025 174
TABLE 154 COLGATE-PALMOLIVE COMPANY: COMPANY OVERVIEW 176
TABLE 155 COLGATE-PALMOLIVE COMPANY: PRODUCTS OFFERED 177
TABLE 156 COLGATE-PALMOLIVE COMPANY: PRODUCT LAUNCHES,
JANUARY 2022–JUNE 2025 178
TABLE 157 COLGATE-PALMOLIVE COMPANY: DEALS, JANUARY 2022–JUNE 2025 178
TABLE 158 COLGATE-PALMOLIVE COMPANY: OTHER DEVELOPMENTS,
JANUARY 2022–JUNE 2025 179
TABLE 159 PROCTER & GAMBLE: COMPANY OVERVIEW 181
TABLE 160 PROCTER & GAMBLE: PRODUCTS OFFERED 182
TABLE 161 PROCTER & GAMBLE: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 184
TABLE 162 PROCTER & GAMBLE: DEALS, JANUARY 2022–JUNE 2025 184
TABLE 163 HALEON GROUP OF COMPANIES: COMPANY OVERVIEW 186
TABLE 164 HALEON GROUP OF COMPANIES: PRODUCTS OFFERED 187
TABLE 165 HALEON GROUP OF COMPANIES: PRODUCT LAUNCHES,
JANUARY 2022–JUNE 2025 188
TABLE 166 HALEON GROUP OF COMPANIES: DEALS, JANUARY 2022–JUNE 2025 188
TABLE 167 HALEON GROUP OF COMPANIES: EXPANSIONS, JANUARY 2022–JUNE 2025 189
TABLE 168 UNILEVER: COMPANY OVERVIEW 191
TABLE 169 UNILEVER: PRODUCTS OFFERED 192
TABLE 170 UNILEVER: DEALS, JANUARY 2022–JUNE 2025 193
TABLE 171 CHURCH & DWIGHT CO., INC.: COMPANY OVERVIEW 195
TABLE 172 CHURCH & DWIGHT CO., INC.: PRODUCTS OFFERED 196
TABLE 173 CHURCH & DWIGHT CO., INC.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 197
TABLE 174 CHURCH & DWIGHT CO., INC.: DEALS, JANUARY 2022–JUNE 2025 197
TABLE 175 LION CORPORATION: COMPANY OVERVIEW 198
TABLE 176 LION CORPORATION: PRODUCTS OFFERED 199
TABLE 177 LION CORPORATION: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 200
TABLE 178 LION CORPORATION: DEALS, JANUARY 2022–JUNE 2025 200
TABLE 179 LION CORPORATION: EXPANSIONS, JANUARY 2022–JUNE 2025 201
TABLE 180 AMWAY CORP.: COMPANY OVERVIEW 202
TABLE 181 AMWAY CORP.: PRODUCTS OFFERED 203
TABLE 182 SUNSTAR SUISSE S.A.: COMPANY OVERVIEW 204
TABLE 183 SUNSTAR SUISSE S.A.: PRODUCTS OFFERED 205
TABLE 184 SUNSTAR SUISSE S.A.: PRODUCT LAUNCHES, JANUARY 2022–JUNE 2025 206
TABLE 185 PERRIGO COMPANY PLC: COMPANY OVERVIEW 207
TABLE 186 PERRIGO COMPANY PLC: PRODUCTS OFFERED 208
TABLE 187 PERRIGO COMPANY PLC: DEALS, JANUARY 2022–JUNE 2025 209
TABLE 188 DABUR: COMPANY OVERVIEW 210
TABLE 189 DABUR: PRODUCTS OFFERED 211
TABLE 190 DABUR: DEALS, JANUARY 2022–JUNE 2025 212
TABLE 191 HIMALAYA WELLNESS COMPANY: COMPANY OVERVIEW 213
TABLE 192 HIMALAYA WELLNESS COMPANY: PRODUCTS OFFERED 213
TABLE 193 KAO CORPORATION: COMPANY OVERVIEW 214
TABLE 194 KAO CORPORATION: PRODUCTS OFFERED 215
TABLE 195 OPELLA HEALTHCARE GROUP SAS: COMPANY OVERVIEW 216
TABLE 196 OPELLA HEALTHCARE GROUP SAS: PRODUCTS OFFERED 216
TABLE 197 OPELLA HEALTHCARE GROUP SAS: DEALS, JANUARY 2022–JUNE 2025 217
TABLE 198 SMARTMOUTH ORAL HEALTH LABORATORIES: COMPANY OVERVIEW 218
TABLE 199 SMARTMOUTH ORAL HEALTH LABORATORIES: PRODUCTS OFFERED 218
TABLE 200 SMARTMOUTH ORAL HEALTH LABORATORIES: PRODUCT LAUNCHES,
JANUARY 2022–JUNE 2025 219
TABLE 201 DENTAID: COMPANY OVERVIEW 219
TABLE 202 CLOSYS: COMPANY OVERVIEW 220
TABLE 203 SCANDERRA GMBH: COMPANY OVERVIEW 221
TABLE 204 PEARLIE WHITE: COMPANY OVERVIEW 222
TABLE 205 WILD: COMPANY OVERVIEW 223
TABLE 206 BOKA: COMPANY OVERVIEW 224
TABLE 207 PERFORA: COMPANY OVERVIEW 225
TABLE 208 SALT ORAL CARE: COMPANY OVERVIEW 226
TABLE 209 ORABIO: COMPANY OVERVIEW 227
TABLE 210 LUMINEUX: COMPANY OVERVIEW 228
FIGURE 1 ORAL RINSES MARKET SEGMENTATION & REGIONAL SCOPE 25
FIGURE 2 ORAL RINSES MARKET: YEARS CONSIDERED 27
FIGURE 3 ORAL RINSES MARKET: RESEARCH DESIGN 29
FIGURE 4 ORAL RINSES MARKET: KEY DATA FROM SECONDARY SOURCES 31
FIGURE 5 ORAL RINSES MARKET: KEY PRIMARY DATA SOURCES 31
FIGURE 6 ORAL RINSES MARKET: KEY DATA FROM PRIMARY SOURCES 32
FIGURE 7 ORAL RINSES MARKET: KEY INSIGHTS FROM INDUSTRY EXPERTS 33
FIGURE 8 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY- AND
DEMAND-SIDE PARTICIPANTS 33
FIGURE 9 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 34
FIGURE 10 ORAL RINSES SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2024) 35
FIGURE 11 REVENUE SHARE ANALYSIS FOR HALEON GROUP OF COMPANIES (2024) 35
FIGURE 12 ORAL RINSES MARKET: SUPPLY-SIDE ANALYSIS (2024) 36
FIGURE 13 ORAL RINSES MARKET: CAGR PROJECTIONS (SUPPLY-SIDE ANALYSIS) 36
FIGURE 14 ORAL RINSES MARKET: BOTTOM-UP APPROACH (SUPPLY-SIDE ANALYSIS) 37
FIGURE 15 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES (2025–2030) 38
FIGURE 16 ORAL RINSES MARKET: TOP-DOWN APPROACH 39
FIGURE 17 ORAL RINSES MARKET: DATA TRIANGULATION METHODOLOGY 40
FIGURE 20 ORAL RINSES MARKET, BY DISTRIBUTION CHANNEL,
2025 VS. 2030 (USD MILLION) 43
FIGURE 21 ORAL RINSES MARKET: REGIONAL SNAPSHOT 44
FIGURE 22 RISING AWARENESS OF PREVENTIVE DENTAL CARE AND ORAL
HYGIENE TO DRIVE MARKET 45
FIGURE 23 JAPAN AND THERAPEUTIC RINSES ACCOUNTED FOR LARGEST ASIA PACIFIC ORAL RINSES MARKET SHARE IN 2024 46
FIGURE 24 INDIA TO GROW AT HIGHEST CAGR DURING STUDY PERIOD 47
FIGURE 25 NORTH AMERICA TO COMMAND LARGEST MARKET SHARE
DURING FORECAST PERIOD 47
FIGURE 26 EMERGING MARKETS TO REGISTER HIGHER GROWTH RATES FROM
2025 TO 2030 48
FIGURE 27 ORAL RINSES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 49
FIGURE 28 ORAL RINSES MARKET: ECOSYSTEM ANALYSIS 57
FIGURE 29 ORAL RINSES MARKET: VALUE CHAIN ANALYSIS 59
FIGURE 30 ORAL RINSES MARKET: PORTER’S FIVE FORCES ANALYSIS 60
FIGURE 31 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY DISTRIBUTION CHANNEL 62
FIGURE 32 KEY BUYING CRITERIA FOR MAJOR DISTRIBUTION CHANNELS 62
FIGURE 33 ORAL RINSES MARKET: SUPPLY CHAIN ANALYSIS 64
FIGURE 34 TOP PATENT APPLICANTS/OWNERS (COMPANIES/INSTITUTES) FOR ORAL RINSES MARKET (JANUARY 2014–DECEMBER 2024) 70
FIGURE 35 TOP PATENT APPLICANT COUNTRIES FOR ORAL RINSES MARKET
(JANUARY 2014–DECEMBER 2024) 71
FIGURE 36 MARKETS ADJACENT TO ORAL RINSES MARKET 73
FIGURE 37 ORAL RINSES MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 73
FIGURE 38 ORAL RINSES MARKET: FUNDING AND NUMBER OF DEALS, 2019–2023 78
FIGURE 39 ORAL RINSES MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 103
FIGURE 40 NORTH AMERICA: ORAL RINSES MARKET SNAPSHOT 105
FIGURE 41 ASIA PACIFIC: ORAL RINSES MARKET SNAPSHOT 128
FIGURE 42 REVENUE SHARE ANALYSIS OF KEY PLAYERS IN ORAL RINSES
MARKET (2020–2024) 154
FIGURE 43 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ORAL RINSES MARKET (2024) 155
FIGURE 44 ORAL RINSES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 157
FIGURE 45 ORAL RINSES MARKET: COMPANY FOOTPRINT 159
FIGURE 46 ORAL RINSES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 164
FIGURE 47 EV/EBITDA OF KEY VENDORS 166
FIGURE 48 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS 166
FIGURE 49 ORAL RINSES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 167
FIGURE 50 ORAL RINSES MARKET: R&D EXPENDITURE OF KEY PLAYERS (2022–2024) 168
FIGURE 51 KENVUE: COMPANY SNAPSHOT 172
FIGURE 52 COLGATE-PALMOLIVE COMPANY: COMPANY SNAPSHOT 177
FIGURE 53 PROCTER & GAMBLE: COMPANY SNAPSHOT 182
FIGURE 54 HALEON GROUP OF COMPANIES: COMPANY SNAPSHOT 187
FIGURE 55 UNILEVER: COMPANY SNAPSHOT 192
FIGURE 56 CHURCH & DWIGHT CO., INC.: COMPANY SNAPSHOT 196
FIGURE 57 LION CORPORATION: COMPANY SNAPSHOT 199
FIGURE 58 AMWAY CORP.: COMPANY SNAPSHOT 202
FIGURE 59 SUNSTAR SUISSE S.A.: COMPANY SNAPSHOT 205
FIGURE 60 PERRIGO COMPANY PLC: COMPANY SNAPSHOT 208
FIGURE 61 DABUR: COMPANY SNAPSHOT 211
FIGURE 62 KAO CORPORATION: COMPANY SNAPSHOT 215
同分類最新報告（醫療器材）
查看醫療器材全部報告 →
量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們